scholarly journals Changes in the epidemiology of hepatitis B virus infection following the implementation of immunisation programmes in northeastern Greece

2009 ◽  
Vol 14 (32) ◽  
Author(s):  
G Zacharakis ◽  
S Kotsiou ◽  
M Papoutselis ◽  
N Vafiadis ◽  
F Tzara ◽  
...  

The objective of this study was to investigate changes in the epidemiology of hepatitis B virus infection in the general population and selected groups of immigrants in the region of northeastern Greece over the last decade in relation to the introduction of hepatitis B vaccination programmes. Two population-based seroprevalence surveys were carried out during the years 1992-1994 and 1998-2006. In total, 25,105 individuals were tested for the presence of hepatitis B virus markers: HBsAg, anti-HBs and anti-HBc. Childhood/adolescence immunisation programmes began early in 1994 in selected groups of immigrants and were complemented by the national vaccination programme in 1998. Between 1992-1994 and 1998-2006, the HBsAg carrier rate declined from 5.4% [95% CI: 4.5-5.9] in adults (20-60 years old) and 1.9% [95% CI: 1.6-2.4] in children/adolescents (5-19 years old) of indigenous residents to 3.4% [95% CI: 2.9-3.8] and 0.6% [95% CI: 0.2-1.4] respectively (p<0.05). In spite of a decrease compared with 1992-1994, the percentage of HBsAg carriers was still relatively high in 1998-2006 among the Muslim religious minority group (8.2% [95% CI: 8.0-8.7] in adults and 2% [95% CI: 1.7-2.4] in children/adolescents) and in immigrants from the former Soviet Union (4.3% [95% CI: 3.6-4.7] in adults and 1.1% [95% CI: 0.8-2.4] in children/adolescents) (p<0.05 for both selected groups versus general population). The decline of the prevalence of HBsAg in the general population and selected groups of immigrants in northeastern Greece over the last decade supports the effectiveness of the ongoing immunisation programme although the information on the actual number of cases of acute HBV infection is not available.

1970 ◽  
Vol 10 (2) ◽  
pp. 67-76 ◽  
Author(s):  
Md Abdul Ahad ◽  
Md Abdul Alim ◽  
Abhijit Guho ◽  
Quazi Tarikul Islam ◽  
Khan Abul Kalam Azad

Hepatitis B virus infection is an important public health problem with significant morbidity and mortality. Recombinant hepatitis B vaccination for the prevention of hepatitis B virus infection is in practice in different parts of the world since its availability in 1986. Government of Bangladesh has also included hepatitis B vaccine in EPI schedule since 2005. This study was carried out to assess the seroconversion status among hepatitis B vaccinated individuals. A total of 190 individuals including 150 vaccinated persons and 40 non-vaccinated apparently healthy individuals were included as study population. Sources of vaccinated persons were from both EPI and non-EPI schedule of vaccination. Age and sex matched non-vaccinated individuals served as controls for the study. All individuals constituting the study population were screened for HBsAg by Immunochromatographic strip test and only HBsAg-negative persons were included for estimation of their anti-HBs titer. Out of 150 vaccinated individuals, 133(88.67%) were found to have anti-HBs titer in the protective level (e"10 IU/L), while 17(11.33%) individuals had anti-HBs titer below the protective level (<10 IU/L). All non-vaccinated controls had anti- HBs titers below the protective level. Immune response developed among vaccinated individuals, 67.78%, 23.33% and 8.89% were good-responders, hypo-responders and non-responders respectively. Mean titer of anti-HBs was found significantly higher among recipients who received booster dose than those who received 3 doses schedule (863.39 IU/L vs. 262.40 IU/L), indicating high antibody titer develops after booster dose. Vaccinated group included 85 (56.67%) men and 65 (43.33%) women with protective level of anti-HBs titer found in 85.88% male and 92.31% female individuals.   doi: 10.3329/jom.v10i2.2817 J MEDICINE 2009; 10 : 67-76


1993 ◽  
Vol 167 (1) ◽  
pp. 203-207 ◽  
Author(s):  
F. J. Mahoney ◽  
B. A. Woodruff ◽  
J. J. Erben ◽  
P. J. Coleman ◽  
E. C. Reid ◽  
...  

Vaccine ◽  
2015 ◽  
Vol 33 (46) ◽  
pp. 6161-6163 ◽  
Author(s):  
Eyasu H. Teshale ◽  
Saleem Kamili ◽  
Jan Drobeniuc ◽  
Maxine Denniston ◽  
Barnabas Bakamutamaho ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document